Sign In
Buy PLSE
$24.99
+0.710 (+2.92%)
At Close: Jun 03, 2026
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2021 Results - Earnings Call Transcript
10:52pm, Monday, 10'th May 2021
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2021 Results - Earnings Call Transcript
Pulse Biosciences to Participate in Upcoming Investor Conferences
08:00am, Friday, 05'th Mar 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to parti
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2020 Results - Earnings Call Transcript
09:53pm, Monday, 22'nd Feb 2021
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2020 Results - Earnings Call Transcript
Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021
08:00am, Friday, 12'th Feb 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report
Pulse Biosciences Announces CE Mark Approval for CellFX® System
08:00am, Monday, 25'th Jan 2021
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS
Pulse Biosciences Grants Equity Incentive Awards To New Employees
04:38pm, Tuesday, 15'th Dec 2020
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”) a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS�
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that a scientif
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2020 Results - Earnings Call Transcript
09:36pm, Monday, 09'th Nov 2020
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2020 Results - Earnings Call Transcript
